Higher maintenance doses of tirzepatide are generally associated with greater average weight loss in clinical trials
It is also worth noting that adding ingredients may affect the safety, absorption, or effectiveness of the GLP-1 medication
The researchers also noted that 23.5% (95% CI, 22.3-24.8) of people meeting FDA indications for tirzepatide reported using medications that may slow gastrointestinal motility, which could increase gastrointestinal adverse effects when combined with any GLP-1 receptor agonist
Pre-Workout Supplements (00:39:04) Acknowledgements Disclaimer & Disclosures Learn more about your ad choices
Among GLP-1RAs, oral semaglutide has a distinct absorption profile compared to once-weekly subcutaneous semaglutide
[DOI] [PubMed] [Google Scholar] 19.Paolisso G., Giugliano D., Pizza G., Gambardella A., Tesauro P., Varricchio M., DOnofrio F